Therefore, we planned to investigate the association between the expression of Shh/Nrf2 and the presence of CTCs to establish these biomarkers as prognostic markers for early diagnosis and therapeutic management in HNSCC. Here, NFE2L2 is linked to head and neck squamous cell carcinoma.